Substituted azaquinazolines having an antiviral action

US7662822B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Tobias Wunberg · Mödling, AT
• Judith Baumeister · Wuppertal, DE
• Mario Jeske · Solingen, DE
• Frank Süβmeier · Birkenfeld, DE
• Holger Zimmermann · Falkensee, DE
• Kerstin Henninger · Wuppertal, DE
• Dieter Lang · Velbert, DE

Key dates

• Filing date: Apr 23, 2005
• Grant date: Feb 16, 2010
• Expiry date: Aug 2, 2025

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/22
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to substituted azaquinazolines, to a process for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses.